Single User License
INR 161450
Site License
INR 322900
Corporate User License
INR 484350

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Intestinal Cancer Global Clinical Trials Review, H1, 2015

Intestinal Cancer Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2586CTIDB
  • |
  • Pages: 247
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Intestinal Cancer Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intestinal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Intestinal Cancer 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Intestinal Cancer 25

Subjects Recruited Over a Period of Time 50

Clinical Trials by Sponsor Type 51

Prominent Sponsors 52

Top Companies Participating in Intestinal Cancer Therapeutics Clinical Trials 53

Prominent Drugs 54

Clinical Trial Profiles 55

Clinical Trial Overview of Top Companies 55

F. Hoffmann-La Roche Ltd. 55

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55

Sanofi 73

Clinical Trial Overview of Sanofi 73

Pfizer Inc. 82

Clinical Trial Overview of Pfizer Inc. 82

Amgen Inc. 88

Clinical Trial Overview of Amgen Inc. 88

Novartis AG 93

Clinical Trial Overview of Novartis AG 93

Bristol-Myers Squibb Company 97

Clinical Trial Overview of Bristol-Myers Squibb Company 97

AstraZeneca PLC 101

Clinical Trial Overview of AstraZeneca PLC 101

E. Merck KG 105

Clinical Trial Overview of E. Merck KG 105

Otsuka Holdings Co., Ltd. 109

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 109

Bayer AG 112

Clinical Trial Overview of Bayer AG 112

Clinical Trial Overview of Top Institutes / Government 115

National Cancer Institute 115

Clinical Trial Overview of National Cancer Institute 115

Memorial Sloan Kettering Cancer Center 131

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 131

University of Texas M. D. Anderson Cancer Center 135

Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 135

European Organization for Research and Treatment of Cancer 138

Clinical Trial Overview of European Organization for Research and Treatment of Cancer 138

Sun Yat-sen University 141

Clinical Trial Overview of Sun Yat-sen University 141

FUDAN University 143

Clinical Trial Overview of FUDAN University 143

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145

Clinical Trial Overview of Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 145

Cancer Research UK 147

Clinical Trial Overview of Cancer Research UK 147

City of Hope 149

Clinical Trial Overview of City of Hope 149

NCIC Clinical Trials Group 151

Clinical Trial Overview of NCIC Clinical Trials Group 151

Five Key Clinical Profiles 153

Appendix 244

Abbreviations 244

Definitions 244

Research Methodology 245

Secondary Research 245

About GlobalData 246

Contact Us 246

Disclaimer 246

Source 247

List of Figures

Intestinal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50

Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 51

Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52

Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53

Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54

GlobalData Methodology 245

List of Tables

Intestinal Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7

Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Intestinal Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Intestinal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27

Intestinal Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 31

Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 50

Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 51

Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 52

Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 53

Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 54

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 55

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 73

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 82

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 88

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 93

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 97

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 101

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 105

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 109

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 112

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 115

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 131

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015* 135

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015* 138

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 141

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 143

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, 2015* 145

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2015* 147

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 149

Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015* 151

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Intestinal Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Intestinal Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com